InforMedix and McKesson BioServices Co-Present Their Integrated Technology Platform for Clinical Studies at PARCS Conference.ROCKVILLE, Md. -- Medication Compliance Monitor, Electronic Patient Diary A Patient Diary is a tool used during a clinical trial or a disease treatment to measure treatment compliance. An Electronic Patient Diary registers the diary in a storage device and allows for monitoring the time the medication was taken. , Specialized Drug Packaging Combined Into One Integrated Solution InforMedix Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :IFMX IFMX Informix Corporation ) announced today that InforMedix and McKesson BioServices, presented "How Technology can Improve Medication- and Protocol-compliance in Clinical Trials," at the Pacific Region Clinical Supplies (PARCS PARCS Primary Atomic Reference Clock in Space PARCS Purdue Advanced Reactor Core Simulator PARCS Perimeter Acquisition Radar Characterization System PARCS Portable Autonomous Report Collection System (radar) ) meeting, held in San Francisco San Francisco (săn frănsĭs`kō), city (1990 pop. 723,959), coextensive with San Francisco co., W Calif., on the tip of a peninsula between the Pacific Ocean and San Francisco Bay, which are connected by the strait known as the Golden , October 8, 2004. The presentation focused on how the integrated delivery platform combines InforMedix's electronic hand-held patient monitoring device with McKesson BioService's clinical trial drug packaging design, to help optimize monitoring of patient medication compliance and data-gathering in large organized clinical studies. Randy Dulin, InforMedix vice president, and Joa Haas, McKesson BioServices regional sales manager sales manager n → gerente m/f de ventas sales manager n → directeur commercial sales manager sale n → gave the presentation. Through a recently announced strategic alliance between McKesson and InforMedix, McKesson BioServices' specialty clinical trial material packaging has been combined with InforMedix's Med-eMonitor(TM) and Med-eXpert Systems(TM), to provide the first integrated solution to the clinical trials market that manages medication administration, patient medication compliance and safety, and the simultaneous capture of electronic diary data. The first clinical study to use this integrated solution was also recently announced, a pioneering study of remote rural diabetic patients to monitor their responses to medication, including the relationship between medication compliance, blood glucose blood glucose Diabetology The principal sugar produced by the body from food–especially carbohydrates, but also from proteins and fats; glucose is the body's major source of energy, is transported to cells via the circulation and used by cells in the presence and HbA1c levels, at St. Vincent Healthcare, Billings Montana. St. Vincent is the network hub See hub and hub vs. switch. for the Partners in Health Telemedicine Network, which has global connectivity capabilities, and also has tested telemedicine equipment used by NASA NASA: see National Aeronautics and Space Administration. NASA in full National Aeronautics and Space Administration Independent U.S. for monitoring astronauts in space. "Non-compliant patients can generate unnecessary expense in developing statistically reliable patient data sets in large clinical trials," noted David Bernstein, Ph.D., vice president of pharmaceutical sciences and regulatory compliance for Cato Research, and the organizer of the PARCS meeting. "The InforMedix/McKesson BioServices team addressed how their solution may aid in enhancing overall patient compliance, as well as streamlining the logistics of remote patient data-gathering. Mr. Dulin and Ms. Haas addressed the practical aspects of gathering high-quality patient data." InforMedix chairman and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , Bruce A. Kehr, M.D., remarked "Our integrated technology solution captures real-time dose-response data for clinical trials and disease management applications, and provides for remote patient monitoring to improve medication compliance, protocol adherence and medication safety. We are delighted that through the McKesson BioServices alliance we were able to jointly present this solution at the PARCS meeting. Additional alliance business development activities are already underway." The PARCS organization brings together regional groups devoted to dissemination dissemination Medtalk The spread of a pernicious process–eg, CA, acute infection Oncology Metastasis, see there , sharing and discussion of technology, logistics, regulatory issues and best practices involved in implementing the investigational clinical supply process of clinical trial drugs. About InforMedix InforMedix has developed the Med-eMonitor System to provide real-time medical management and patient communications for clinical drug trials. InforMedix has integrated a portable patient-interactive monitoring device, hardware, software and networked communications system In telecommunication, a communications system is a collection of individual communications networks, transmission systems, relay stations, tributary stations, and data terminal equipment (DTE) usually capable of interconnection and interoperation to form an integrated whole. to enable pharmaceutical and biotechnology companies Top 100 Biotechnology Companies The following is a list of the top 100 biotechnology companies ranked by revenue. The first nine companies qualify for the list of the top 50 pharmaceutical companies. , and medical researchers to efficiently monitor and manage patients' medication compliance, protocol adherence, clinical response, and safety. Med-eMonitor is specifically designed to improve patient medication compliance and protocol adherence in clinical drug trials. The Med-eMonitor System leverages InforMedix's strong intellectual property consisting of 15 issued patents and 14 patents pending. InforMedix's patents have been cited as prior art by patent examiners A patent examiner or patent clerk is an employee, usually a civil servant, working within a patent office. Major employers of patent examiners are the European Patent Office (EPO), the United States Patent and Trademark Office (USPTO) and the Japan Patent Office. in over 150 other issued patents. To find out more about InforMedix, Inc. (OTCBB:IFMX), visit our website at www.informedix.com. About McKesson BioServices Understanding the critical drug development process, McKesson BioServices experienced staff has extensive domestic and worldwide shipping expertise working closely with clients to support any clinical trial and address special needs involved in handling clinical trial material. McKesson BioServices is a leader in the management, packaging and labeling, analytical testing, validation testing, storage and distribution of clinical trial materials and biological specimens covering preclinical preclinical /pre·clin·i·cal/ (-klin´i-k'l) before a disease becomes clinically recognizable. pre·clin·i·cal adj. 1. through Phase IV studies. BioServices also provides patient-specific pharmacy services nationwide to support patient assistance programs for commercial pharmaceutical products. For information about McKesson BioServices' wide array of services, visit www.mckessonbio.com. Our parent company, McKesson Corporation is a Fortune 16 healthcare services and information technology company dedicated to helping its customers deliver high-quality healthcare by reducing costs, streamlining processes and improving the quality and safety of patient care. Over the course of its 170 year history, McKesson has grown to provide pharmaceutical and medical-surgical supply management across the spectrum of care; healthcare information technology for hospitals, physicians, homecare and payors; hospital and retail pharmacy automation; and services for manufacturers and payors designed to improve outcomes for patients. For more information, visit www.mckesson.com. InforMedix Safe Harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. Provisions This report contains "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbors created thereby. These statements include the first clinical study to use this integrated solution. Recently the Company announced a pioneering study of remote rural diabetic patients that will monitor their responses to medication, including the relationship between medication compliance, blood glucose and HbA1c levels, at St. Vincent Healthcare, Billings Montana. References made to the discussion of the risk factors are detailed in InforMedix's filings with the Securities and Exchange Commission, including the report on Form 10-QSB for the quarter ended June 30, 2004, their Annual Report on Form 10-KSB for the year ended December 31, 2003, their prospectus dated May 28, 2004 and their other filings with the U.S. Securities and Exchange Commission. These forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. are made only as of the date hereof, and InforMedix disclaims any obligation to update or revise the information contained in any such forward-looking statements, whether as a result of new information, future events or otherwise. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion